Non-Hodgkin’s lymphoma – Diagnostics – Overview of Information and Clinical Research

Diagnosing Non-Hodgkin lymphoma involves a careful series of tests and examinations that help doctors identify the disease, understand its type and severity, and plan the most suitable treatment approach for each person.

Introduction: Who Should Undergo Diagnostics

If you notice painless swelling in your neck, armpits, or groin that doesn’t go away after a few weeks, it’s important to see a healthcare provider. This swelling might be a sign of enlarged lymph nodes, which are small, bean-shaped organs that help your body fight infections.^[1]^[2] While many conditions can cause lymph nodes to swell, persistent enlargement could indicate Non-Hodgkin lymphoma and should be checked by a doctor.

You should also seek medical attention if you experience other symptoms that last for several weeks. These include ongoing tiredness, unexplained fever (especially one that stays high or lasts for more than two days), night sweats so intense they soak your sheets, or losing 10% of your body weight over six months without trying.^[2]^[13] Some people might notice chest pain, coughing, or trouble breathing, while others experience belly pain, swelling, or feeling full even when they haven’t eaten much.^[1]^[2]

It’s important to remember that many other conditions share these symptoms, so having one or more doesn’t necessarily mean you have Non-Hodgkin lymphoma. However, any changes in your body that persist for several weeks deserve attention from a healthcare professional.^[2] Early detection allows for timely treatment planning and better management of the disease.

Doctors particularly look for what they call B symptoms when evaluating patients. These specific symptoms include fever, night sweats, and unexplained weight loss. They help doctors classify the type of Non-Hodgkin lymphoma you might have and determine how aggressive it is.^[2]^[13] If you’re experiencing these symptoms along with swollen lymph nodes, it’s especially important to get evaluated promptly.

⚠️ Important

Not all enlarged lymph nodes mean cancer. Infections and other conditions commonly cause lymph nodes to swell temporarily. The key difference is that lymph nodes affected by Non-Hodgkin lymphoma are usually painless and don’t shrink after a few weeks. If your swollen lymph nodes are accompanied by fever, weight loss, or night sweats that last longer than two weeks, contact your doctor without delay.

Diagnostic Methods

When doctors suspect Non-Hodgkin lymphoma, they use several tests to confirm the diagnosis and understand the disease better. The diagnostic process typically starts with simpler examinations and progresses to more detailed tests as needed.^[9]^[21]

Physical Examination

The first step in diagnosing Non-Hodgkin lymphoma is a thorough physical examination. Your doctor will carefully check for swollen lymph nodes in your neck, underarms, and groin by gently feeling these areas. They will also check whether your spleen or liver feels enlarged, as these organs can be affected by the disease.^[9]^[21] During this examination, your doctor will ask detailed questions about your symptoms, how long you’ve had them, and whether anything makes them better or worse.

Blood and Urine Tests

Blood and urine tests help doctors rule out infections or other diseases that might cause similar symptoms. These tests examine your blood cells to check for abnormalities. They can show whether your red blood cell count is low (called anemia), whether you have enough white blood cells to fight infections, or if your blood is clotting properly.^[9]^[21] While blood tests alone cannot confirm Non-Hodgkin lymphoma, they provide important information about your overall health and help guide further testing.

Lymph Node Biopsy

The only way to definitively confirm a diagnosis of Non-Hodgkin lymphoma is through a biopsy. This is a minor surgical procedure where doctors remove a sample of affected lymph node tissue for detailed examination in a laboratory.^[3]^[9] The biopsy can involve removing all or part of a lymph node. In the laboratory, specialists study the tissue under a microscope to look for cancer cells and determine the specific type of lymphoma you might have.

There are different types of biopsies depending on where the affected lymph node is located and how accessible it is. Sometimes doctors can remove the entire lymph node through a small incision. In other cases, they might use a needle to extract a sample of tissue. The type of biopsy your doctor recommends will depend on your individual situation.^[9]^[21]

Bone Marrow Tests

Bone marrow tests help doctors determine whether Non-Hodgkin lymphoma has spread to the bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. These tests include bone marrow aspiration and bone marrow biopsy.^[9]^[21] In bone marrow aspiration, a doctor uses a thin needle to remove a small amount of liquid bone marrow, usually from a spot in the back of your hip bone. In a bone marrow biopsy, performed at the same time, a needle removes a small piece of bone tissue along with the enclosed marrow. Both samples are then sent to a laboratory for testing.

Imaging Tests

Imaging tests create pictures of the inside of your body and help doctors see where lymphoma cells might be located. These tests are essential for understanding how far the disease has spread and planning treatment.^[9]^[21]

CT scans (computed tomography) use X-rays and computers to create detailed, three-dimensional images of your body. Doctors use CT scans to look for enlarged lymph nodes in your chest, belly, and pelvis, as well as to check other organs for signs of lymphoma.^[5]^[9]

MRI scans (magnetic resonance imaging) use powerful magnets and radio waves instead of X-rays to create detailed images of your body’s soft tissues. MRI scans are particularly useful for looking at the brain and spinal cord if doctors need to check whether lymphoma has spread to these areas.^[9]

PET scans (positron emission tomography) work differently from other imaging tests. Before the scan, you receive a small amount of radioactive sugar through a vein. Cancer cells, which grow quickly, absorb more of this sugar than normal cells. The PET scanner then detects where this sugar has collected, showing doctors where cancer might be present throughout your body.^[9]^[21] PET scans are especially helpful for seeing whether lymphoma has spread to areas that might not show up clearly on other imaging tests.

Additional Specialized Tests

Once doctors confirm you have Non-Hodgkin lymphoma through a biopsy, they perform additional tests on the tissue sample to learn more about the specific type of lymphoma. These tests examine the characteristics of the cancer cells, including their appearance under a microscope, what proteins they contain, and whether they have any genetic changes. This information is crucial because there are more than 70 different subtypes of Non-Hodgkin lymphoma, and each type may require different treatment approaches.^[2]^[13]

⚠️ Important

The diagnostic process may feel overwhelming, especially when multiple tests are needed. Remember that each test provides specific information that helps your healthcare team create the most effective treatment plan for your situation. Don’t hesitate to ask your doctor to explain why each test is needed and what they expect to learn from it. Bringing a family member or friend to appointments can help you remember the information discussed.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or ways of using existing treatments for Non-Hodgkin lymphoma. If you’re considering joining a clinical trial, you’ll need to undergo specific tests to determine whether you’re eligible to participate. These tests ensure that the study is safe for you and that researchers can accurately measure how well the treatment works.^[7]

Before enrolling in a clinical trial, doctors need detailed information about your type of Non-Hodgkin lymphoma, how far it has spread, and your overall health. This means you’ll likely undergo many of the same diagnostic tests used for initial diagnosis, even if you’ve already had them before. Fresh test results help researchers understand your current condition and track any changes during the trial.^[7]

Most clinical trials require a confirmed diagnosis through biopsy results showing the specific type of Non-Hodgkin lymphoma you have. Some trials only accept patients with certain subtypes of the disease, while others may be open to multiple types. The biopsy samples are often reviewed again by specialists involved in the trial to ensure the diagnosis is correct.^[9]^[21]

Imaging tests such as CT scans, MRI scans, or PET scans are standard requirements for clinical trial enrollment. These tests establish a baseline showing where the lymphoma is located and how large the tumors are when you start the trial. Researchers use this baseline to compare with later scans and determine whether the treatment is working. Some trials require specific types of imaging at particular intervals throughout the study.^[9]^[21]

Blood tests are essential for clinical trial qualification because they assess whether your body can safely handle the experimental treatment. Doctors check your blood cell counts to ensure you have enough red blood cells, white blood cells, and platelets. They also test how well your liver and kidneys are functioning, as these organs process many medications. If your organ function is too impaired, you might not be able to safely participate in certain trials.^[9]^[21]

Bone marrow testing may be required depending on the trial’s focus. If the experimental treatment affects how your bone marrow produces blood cells, or if researchers need to know whether lymphoma is present in your bone marrow, you’ll need to undergo bone marrow aspiration and biopsy. These tests provide crucial information about your bone marrow’s health and function before treatment begins.^[9]^[21]

Some clinical trials also require specialized testing that isn’t part of routine diagnosis. For example, if a trial is testing a companion diagnostic—a treatment that targets specific characteristics of cancer cells—you might need molecular or genetic testing on your tumor tissue. These tests identify whether your cancer cells have particular markers or mutations that the experimental treatment is designed to target.^[7] Without these markers, the treatment likely wouldn’t be effective for you.

Clinical trials often have specific criteria about previous treatments. The qualification process includes documenting what treatments you’ve already received, how long ago you had them, and how you responded. Some trials are only for people who haven’t been treated before, while others specifically seek patients whose cancer has returned after previous treatment or hasn’t responded to standard therapies.^[7]

Your overall health status, often measured by what doctors call performance status, is another important factor in clinical trial eligibility. This assessment considers how well you can carry out daily activities and whether you spend most of your time in bed or a chair. Many trials only accept patients who are relatively active and can care for themselves, though some studies specifically focus on patients with more advanced illness.^[7]

Throughout the enrollment process, the research team will explain what tests are needed and why. They’ll also tell you how often tests will be repeated during the trial and what happens with your test results. All clinical trials must follow strict ethical guidelines to protect participants, and you have the right to ask questions about any test or procedure before agreeing to participate.^[7]

Prognosis and Survival Rate

Prognosis

The outlook for people with Non-Hodgkin lymphoma varies greatly depending on several factors. These include the specific subtype of lymphoma, whether it’s classified as indolent (slow-growing) or aggressive (fast-growing), the stage of disease at diagnosis, your age, and your overall health.^[2]^[7] Indolent lymphomas tend to grow slowly and people can live with them for many years, though they are usually harder to cure completely. While these slow-growing types have a relatively good prognosis, with some people living 20 years or more, they often require ongoing treatment or monitoring.^[12]^[15]

Aggressive lymphomas grow and spread more quickly and require immediate, intensive treatment. However, these types often respond better to treatment and can frequently be cured.^[2]^[7]^[13] Modern treatments have significantly improved outcomes, with more than 70% of patients with aggressive Non-Hodgkin lymphoma achieving cure.^[12] The presence of B symptoms (fever, night sweats, and unexplained weight loss) also influences prognosis, as these symptoms help doctors classify how aggressive the lymphoma is.^[2]

Survival rate

Overall, with modern treatments, the 5-year survival rate for all types of Non-Hodgkin lymphoma is over 60%.^[12] This means that more than 6 out of 10 people diagnosed with Non-Hodgkin lymphoma are alive five years after their diagnosis. For aggressive types of lymphoma, most people who experience relapse do so within the first two years after treatment. After this period, the risk of relapse decreases significantly.^[12]^[15] Thanks to advances in diagnosis and treatment, people with Non-Hodgkin lymphoma are living longer than ever before.^[1]^[2] It’s important to remember that survival statistics are general estimates based on large groups of people, and your individual outlook depends on many personal factors that your healthcare team can discuss with you.